Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 11/2012

01-11-2012 | Annotated Sequence Record

Full-length genome analysis of vesicular stomatitis New Jersey virus strains representing the phylogenetic and geographic diversity of the virus

Authors: Steven J. Pauszek, Luis L. Rodriguez

Published in: Archives of Virology | Issue 11/2012

Login to get access

Excerpt

We describe the complete genomic sequence of nine isolates of vesicular stomatitis New Jersey virus (VSNJV) representing six distinct phylogenetic groups and spanning the known geographic range of the virus. The total genomic length (11,119-11,123 nt) and structure of these isolates were very similar to those of other vesicular stomatitis viruses. There were no differences in the number of amino acids in any of their viral proteins. As expected, the genomic termini, possessing initiation signals for viral transcription and replication, were highly conserved. These complete sequences, the first for natural isolates of VSNJV, should prove useful in the design of molecular detection tests and provide the basis for future functional genomics and pathogenesis studies. …
Literature
1.
Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS (2003) Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77:4646–4657PubMedCrossRef
2.
Barr JN, Whelan SP, Wertz GW (1997) Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J Virol 71:1794–1801PubMed
3.
Bilsel PA, Nichol ST (1990) Polymerase errors accumulating during natural evolution of the glycoprotein gene of vesicular stomatitis virus Indiana serotype isolates. J Virol 64:4873–4883PubMed
4.
Fauquet CM, Fargette D (2005) International Committee on Taxonomy of Viruses and the 3,142 unassigned species. Virol J 2:64PubMedCrossRef
5.
Hanson RP, Estupinan J, Castaneda J (1968) Vesicular stomatitis in the Americas. Bull Off Int Epizoot 70:37–47PubMed
6.
Jayakar HR, Whitt MA (2002) Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol 76:8011–8018PubMedCrossRef
7.
Kim GN, Kang CY (2007) Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression. Virology 357:41–53PubMedCrossRef
8.
9.
Luk D, Masters PS, Gill DS, Banerjee AK (1987) Intergenic sequences of the vesicular stomatitis virus genome (New Jersey serotype): evidence for two transcription initiation sites within the L gene. Virology 160:88–94PubMedCrossRef
10.
Martinez I, Rodriguez LL, Jimenez C, Pauszek SJ, Wertz GW (2003) Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host. J Virol 77:8039–8047PubMedCrossRef
11.
Pattnaik AK, Ball LA, LeGrone A, Wertz GW (1995) The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles. Virology 206:760–764PubMedCrossRef
12.
Pauszek SJ, Allende R, Rodriguez LL (2008) Characterization of the full-length genomic sequences of vesicular stomatitis Cocal and Alagoas viruses. Arch Virol 153:1353–1357PubMedCrossRef
13.
Perez AM, Pauszek SJ, Jimenez D, Kelley WN, Whedbee Z, Rodriguez LL (2010) Spatial and phylogenetic analysis of vesicular stomatitis virus over-wintering in the United States. Prev Vet Med 93:258–264
14.
Rainwater-Lovett K, Pauszek SJ, Kelley WN, Rodriguez LL (2007) Molecular epidemiology of vesicular stomatitis New Jersey virus from the 2004–2005 US outbreak indicates a common origin with Mexican strains. J Gen Virol 88:2042–2051PubMedCrossRef
15.
Rodriguez LL, Fitch WM, Nichol ST (1996) Ecological factors rather than temporal factors dominate the evolution of vesicular stomatitis virus. Proc Natl Acad Sci USA 93:13030–13035PubMedCrossRef
16.
Rodriguez LL (2002) Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res 85:211–219PubMedCrossRef
17.
Rodriguez LL, Pauszek SJ, Bunch TA, Schumann KR (2002) Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America. J Gen Virol 83:2475–2483PubMed
18.
Rose JK (1980) Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell 19:415–421PubMedCrossRef
19.
Schnell MJ, Buonocore L, Whitt MA, Rose JK (1996) The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol 70:2318–2323PubMed
20.
Stillman EA, Whitt MA (1997) Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J Virol 71:2127–2137PubMed
21.
Swofford DL (2003) PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts
22.
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882PubMedCrossRef
23.
von Kobbe C, van Deursen JM, Rodrigues JP, Sitterlin D, Bachi A, Wu X, Wilm M, Carmo-Fonseca M, Izaurralde E (2000) Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell 6:1243–1252CrossRef
24.
Wertz GW, Whelan S, LeGrone A, Ball LA (1994) Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proc Natl Acad Sci USA 91:8587–8591PubMedCrossRef
25.
Whelan SP, Wertz GW (1999) Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication. J Virol 73:297–306PubMed
26.
Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN (2010) Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virol 84:1563–1573
Metadata
Title
Full-length genome analysis of vesicular stomatitis New Jersey virus strains representing the phylogenetic and geographic diversity of the virus
Authors
Steven J. Pauszek
Luis L. Rodriguez
Publication date
01-11-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1420-x

Other articles of this Issue 11/2012

Archives of Virology 11/2012 Go to the issue

Brief Report

Experimental infection of laboratory-bred bank voles (Myodes glareolus) with murid herpesvirus 4

Brief Report

Co-detection in the pathogenesis of severe hand-foot-mouth disease

Original Article

Development of a nested PCR assay to detect equine infectious anemia proviral DNA from peripheral blood of naturally infected horses

Erratum

Erratum to: An overview of infectious bursal disease

Original Article

First complete and productive cell culture model for members of the genus Iridovirus

Original Article

New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits